These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 10360220

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expression of epidermal growth factors and apoptosis markers in pancreatic ductal adenocarcinoma.
    Pryczynicz A, Guzińska-Ustymowicz K, Czyzewska J, Kemona A.
    Folia Histochem Cytobiol; 2009; 47(4):667-71. PubMed ID: 20430737
    [Abstract] [Full Text] [Related]

  • 4. Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis.
    Friess H, Yamanaka Y, Büchler M, Kobrin MS, Tahara E, Korc M.
    Int J Cancer; 1994 Mar 01; 56(5):668-74. PubMed ID: 8314343
    [Abstract] [Full Text] [Related]

  • 5. Expression of heparin-binding epidermal growth factor-like growth factor in pancreatic adenocarcinoma.
    Ito Y, Higashiyama S, Takeda T, Yamamoto Y, Wakasa KI, Matsuura N.
    Int J Pancreatol; 2001 Mar 01; 29(1):47-52. PubMed ID: 11558632
    [Abstract] [Full Text] [Related]

  • 6. Hematopoietic cytokines in the sera of patients with pancreatic cancer.
    Mroczko B, Szmitkowski M, Wereszczyńska-Siemiatkowska U, Jurkowska G.
    Clin Chem Lab Med; 2005 Mar 01; 43(2):146-50. PubMed ID: 15843207
    [Abstract] [Full Text] [Related]

  • 7. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
    Baron AT, Lafky JM, Boardman CH, Balasubramaniam S, Suman VJ, Podratz KC, Maihle NJ.
    Cancer Epidemiol Biomarkers Prev; 1999 Feb 01; 8(2):129-37. PubMed ID: 10067810
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
    Hocker JR, Postier RG, Li M, Lerner MR, Lightfoot SA, Peyton MD, Deb SJ, Baker CM, Williams TL, Hanas RJ, Stowell DE, Lander TJ, Brackett DJ, Hanas JS.
    Cancer Lett; 2015 Apr 10; 359(2):314-24. PubMed ID: 25637792
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA 19-9) values in patients with pancreatic cancer or pancreatitis].
    Changchine CS, Yung CY, Tzen KY.
    Changgeng Yi Xue Za Zhi; 1991 Mar 10; 14(1):32-8. PubMed ID: 2039968
    [Abstract] [Full Text] [Related]

  • 16. Epidermal growth factor serum levels and the 61 G/A polymorphism in patients with acute pancreatitis.
    Papachristou GI, Muddana V, Papachristou DJ, Stello K, Whitcomb DC.
    Dig Dis Sci; 2010 Sep 10; 55(9):2676-80. PubMed ID: 20127414
    [Abstract] [Full Text] [Related]

  • 17. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
    Kramer C, Klasmeyer K, Bojar H, Schulz WA, Ackermann R, Grimm MO.
    Cancer; 2007 May 15; 109(10):2016-24. PubMed ID: 17394193
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum CA 242: the search for a valid marker of pancreatic cancer.
    Ventrucci M, Ubalducci GM, Cipolla A, Panella MA, Ligabue A.
    Clin Chem Lab Med; 1998 Mar 15; 36(3):179-84. PubMed ID: 9589807
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.